1. [Experience in complex therapy ribavine chronic viral hepatitis C].
- Author
-
Domashenko OM
- Subjects
- Adolescent, Adult, Antiviral Agents administration & dosage, Antiviral Agents therapeutic use, Drug Administration Schedule, Drug Dosage Calculations, Female, Genotype, Hepacivirus classification, Hepacivirus physiology, Hepatitis C, Chronic diagnosis, Hepatitis C, Chronic immunology, Hepatitis C, Chronic virology, Humans, Interferon-alpha therapeutic use, Male, Middle Aged, Molecular Typing, RNA, Viral antagonists & inhibitors, Recurrence, Ribavirin therapeutic use, Treatment Outcome, Drug Therapy, Combination methods, Hepacivirus drug effects, Hepatitis C, Chronic drug therapy, Interferon-alpha administration & dosage, Ribavirin administration & dosage, Viral Load drug effects
- Abstract
In 72 patients with chronic hepatitis C aged 18 to 62 years evaluated the clinical efficacy Ribavine in combination therapy with interferon-alpha. The safety, good tolerability and efficacy Ribavine. Persistent virological and biochemical response in the application of interferon-alpha and Ribavine obtained from 47,5 to 53,1%. Recurrence rate was 32,5% in patients with genotype 1 and 21,9% with genotype 2 and 3. Side effects of Ribavine are reversible and leveled after the completion of therapy.
- Published
- 2011